Bill Jacqmein

Bill Jacqmein has extensive work experience in the medical device and biotechnology industry. Bill most recently served as the Chief Executive Officer at Prime Path Medtech starting in October 2019. Prior to that, they worked as the Managing Director - Medical Device/Biotechnology at RCQ Solutions from July 2013 to October 2019. From October 2016 to September 2018, Bill held the role of VP Business Development at Oriel STAT A MATRIX. Bill also served as the COO at Vergent Bioscience from July 2014 to September 2016.

Before joining Vergent Bioscience, Bill held several leadership positions at Galil Medical. From September 2009 to January 2014, they served as the Chief Technology Officer - R&D/Clinical/Regulatory/Operations. Prior to that, they were the Vice President, WW Clinical and Regulatory from January 2008 to September 2009. Bill also worked at Boston Scientific as the Director, Clinical from March 2004 to December 2007.

Earlier in their career, Bill worked at Proxima Therapeutics where they held the positions of Director, Clinical from 2001 to 2004 and Manager Clinical Affairs from 1998 to 2001. Bill also served as a Clinical Program Manager at Sulzer Intermedics from 1995 to 1998 and as a Clinical Research Associate at Cyberonics from 1993 to 1995.

Bill Jacqmein attended Texas A&M University from 1988 to 1992, where they pursued a Bachelor of Science degree in BioEngineering.